Results 231 to 240 of about 8,830 (256)
Some of the next articles are maybe not open access.
A new cholinergic mechanism for antipsychotics: emraclidine and M4 muscarinic receptors
The Lancet, 2022John, Cookson, Ferdinand, Jonsson
openaire +2 more sources
Structure-function studies of M4 muscarinic acetylcholine receptor allosteric modulation
2017The M4 muscarinic acetylcholine receptor (mAChR) is implicated in many central nervous system disorders, however, due to a highly conserved acetylcholine (ACh) binding orthosteric site, there is a lack of highly selective ligands as therapeutics and experimental probes for this target.
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins.
Journal of the peripheral nervous system : JPNS, 2000The distribution of m1-m4 muscarinic acetylcholine receptors was investigated by immunolight and electron microscopy in rat dorsal root ganglia, by using subtype-specific antibodies. The light microscopic observations show that both the intensity and the localisation of immunolabeling of the four muscarinic subtypes are different.
N, Bernardini +2 more
openaire +1 more source
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Centrally-Acting Antagonist of Muscarinic M4 Receptors
Emerging Therapeutic Targets, 1997openaire +1 more source
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly